Search This Blog

Thursday, August 8, 2019

FibroGen EPS of $1.26

FibroGen (NASDAQ:FGEN): Q2 EPS of $1.26 may not be comparable to consensus of -$0.55.
Revenue of $191.57M (+335.9% Y/Y) beats by $162.54M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)